Philips parent Royal Philips has agreed to purchase SpectraWave.
Under terms of the deal, Philips will acquire SpectraWave's HyperVue imaging system for AI-supported imaging inside the coronary arteries, and X1-FFR, an AI-enabled angio-based fractional flow reserve technology for coronary physiology assessment from a single angiogram, it said.
The purchase will expand Philips' existing intravascular imaging and physiological assessment device portfolio, which currently features Eagle Eye Platinum digital IVUS and OmniWire iFR, according to the firm.
